Skip to main content

GOLDMAN SACHS GROUP INC

Position in PRLD — Prelude Therapeutics Inc

CIK 886982 NEW YORK, NY

Position in PRLD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$808,723
+$468,040 QoQ
Shares Held
236,469
+101.3% QoQ
Ownership
0.297%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRLD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. PRLD ranks #266 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PRLD

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $808,723 236,469
2025-12-31 $340,683 117,477
2025-09-30 $114,230 79,327
2025-06-30 $120,685 149,178
2025-03-31 $119,204 155,215
2024-12-31 $189,115 148,326
2024-09-30 $196,983 95,161
2024-06-30 $285,456 74,923
2024-03-31 $319,603 67,427
2023-12-31 $296,615 69,465
2023-09-30 $209,155 67,688
2023-06-30 $107,046 23,788
2023-03-31 $282,127 49,496
2022-12-31 $95,214 15,764
2022-09-30 $143,668 21,735
2022-06-30 $231,219 44,295
2022-03-31 $166,220 24,090
2021-12-31 $1,411,020 113,335
2021-09-30 $270,593 8,659
2021-06-30 $533,004 18,617
2021-03-31 $1,885,244 43,509
2020-09-30 $2,506,816 83,200